investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
TNF Signaling, Cell Death and Cancer
Zheng-Gang Liu
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Identifying new components of necrotic pathway and collecting clinical samples (cancer)
Related projects
Charles Roberts
The function of Snf5, an epigenetic tumor suppressor
All cancers but non-melanoma skin cancer
Hiroaki Mitsuya
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
All cancers but non-melanoma skin cancer
Sun Hur
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
All cancers but non-melanoma skin cancer
Robert A Gatenby
The Physical Microenvironment in Cancer Biology and Therapy
Brain, nervous system
Brian A Cobb
Antigenic Carbohydrate Structure, Function, and Specificity
All cancers but non-melanoma skin cancer
Ninh La-Beck
Abrogating Nanoparticle-induced Immunosuppression in Tumor Microenvironment
All cancers but non-melanoma skin cancer
Matthew L. Meyerson
Genome Characterization Center (GCC)
All cancers but non-melanoma skin cancer
Ronald Wayne Davis
Revolutionizing Biomedical and Clinical Research through Innovative Technology
All cancers but non-melanoma skin cancer
Ronglai Shen
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis
All cancers but non-melanoma skin cancer
